Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
AirTalk

COVID-19: The Week Ahead, Antibody Test, Furloughs Of Medical Staff And More

NEW YORK, NEW YORK - APRIL 03: A man waves from a bus in a neighborhood in the Queens borough, which has one of the highest infection rates of coronavirus in the nation, on April 03, 2020 in New York City. Hospitals in New York City, the nation's current epicenter of the COVID-19 outbreak, are facing shortages of beds, ventilators and protective equipment for medical staff. Currently, over 100, 000 New Yorkers have tested positive for COVID-19. (Photo by Spencer Platt/Getty Images)
A man waves from a bus in a neighborhood in the Queens borough, which has one of the highest infection rates of coronavirus in the nation, on April 03, 2020 in New York City.
(
Spencer Platt/Getty Images
)
Listen 17:52
COVID-19: The Week Ahead, Antibody Test, Furloughs Of Medical Staff And More

The United States is bracing for a painful week, with a wave of coronavirus deaths expected across the nation.

New York City, the U.S. epicenter, New Orleans and Detroit face especially worrying days ahead. Yet President Donald Trump and Vice President Mike Pence are striking optimistic tones, insisting that hard weeks ahead will ultimately lead to the nation beginning to turn a corner.

Meanwhile, new Stanford research is leading to the development of a test to detect protective antibodies, which might be useful in determining whether a healthcare worker can return to work. 

And, perhaps counterintuitively, hospitals are looking at furloughing non-emergency staff. 

We discuss all these latest headlines with our medical expert, and we take your questions. Call ust at 866-893-5722. 

With files from the Associated Press. 

Guest: 

Otto Yang, M.D., infectious disease specialist at the Ronald Reagan UCLA Medical Center and professor of medicine at UCLA; his laboratory specializes in T cell immunology in HIV infection, relevant to developing immune therapies and vaccines for HIV and potentially other diseases including viral infections and cancer